| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $132.0M | -21.7% |
| SG&A Expense | $38.6M | +62.0% |
| Operating Income | -$170.6M | +11.3% |
| Income Tax | $0 | — |
| Net Income | -$154.7M | +13.0% |
| EPS (Basic) | -$2.29 | +37.4% |
| EPS (Diluted) | -$2.29 | +37.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $172.9M | +51.6% |
| Current Assets | $661.4M | +222.1% |
| Total Assets | $661.8M | +221.4% |
| Current Liabilities | $15.1M | +3.2% |
| Stockholders' Equity | $646.7M | +238.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$142.4M | +14.4% |
| Investing Cash Flow | -$389.8M | -439.0% |
| Financing Cash Flow | $591.0M | +408.9% |